Category Archives: Finance

“MARC BEER: THE CAPTAIN OF THE MEDICAL TECHNOLOGY INDUSTRY “

Having graduated from Miami University with a Bachelor of Science situated in Ohio, he has made quite a mark in his career. Marc Beer has delved deeper in the sphere of where technology meets medicine, and this has widely been seen by his indulgence in making wherever company he has been to achieve success, growth and development, a clear indication that not only is he a good leader but the captain of industries in the MedTech industry.

 

On the list of successful entrepreneurs, Marc Beer is on top of it. Recently has been made major news. He has held various positions in the Board of Directors. Genzyme has had Marc Beer as the Vice President of Global Marketing. His major role was being in charge of the launch of the company’s products. He has served in many capacities some of them including sales and marketing executive, Chairman and a member of the Board of directors among other envious positions.

 

Marc Beer CEO and Co-Founder of started Renovia in August 2016 and is the current chairman. With only two years in the industry, it has made impacts. The medical technology is based in Boston, and it helps in creating a difference in people lives by creating devices that help combat pelvic floor disorders. He founded the company with Ramon Iglesias, Yolanda Lorie. His field of expertise is majorly inclined towards the healthcare funding business.

 

Marc Beer has had many work experiences in companies such as ViaCell, a biotechnology company. Under Marc Beer, the company had led a rapid growth with over 300 workers and their specialization if the collection, development, and preservation of the stem cells in the body.

 

With an over 25 years of experience in the commercialization industry of biotechnology, diagnostic industries as well as the pharmaceuticals, Marc Beer has just had a signed deal that is geared towards raising 42 million dollars to help fund a start-up for women health in Renovia Inc. The 42 million dollar funding is considered the B series by Marc Beer and the Renovia company as they have become interested in developing technology that helps women experiencing pelvic disorders floor. This will be done by developing the pelvic disorders treating methods by innovative technology uses.

 

This comes shortly after the Series A funding was used in acquiring another equity for the company. Renovia under Marc Beer has its work geared to bringing new products to the market and thriving in medicine. However, Marc Beer and his team not only have put interest in this major development but also part of the funding has been set aside for the following: Learn more: https://www.benzinga.com/pressreleases/18/08/r12237847/osf-ventures-invests-in-company-developing-solutions-for-pelvic-floor-

 

  • Commercial launches and marketing launches

 

  • Product improvement and development

 

  • Clinical trials for the future

 

Marc Beer & Renovia: Clear For Innovation

Marc Beer, a man of many feats, initially received his Bachelor’s of Science degree from Miami University before delving into the innovation industry. The 54 year old is currently the CEO, co-founder and Chairman of Renovia Inc. with over 25 years of experience in commercialization and evolution in the pharmaceutical, biotechnology, diagnostic and device industries. Prior to his co-founding of Renovia, Marc Beer became the founding CEO of ViaCel during April of 2002. ViaCel is a biotechnology company specializing in the accumulation, conservation, and development of umbilical cord blood stem cells. During a duration of only seven years, he managed to lead the company from its initial commencement to an expeditious expansion and vigorous mercantile coordination. Led by Marc’s leadership, the company expanded to more than 300 employees, and ultimately became public in 2005. The company was conclusively adopted in 2007 by PerkinElmer.

 

Prior to Marc’s role within Genzyme, he acquired various sales and marketing duties in the pharmaceutical and diagnostic sectors of Abbott Laboratories. Additionally, he was formerly a member of the Mass Life Science Board of the Commonwealth of Massachusetts, as he served on the Biotechnology Industry Organization Emerging Companies Section Governing Board. Marc Beer also previously served as a meticulous consultant to OvaScience, which announced their merging with Millendo Therapeutics.

 

During his employment as the CEO of ViaCell, Marc additionally served as a constituent of the board of directors at Erytech Pharma, which is a public bio-pharmaceutical company. Prior to ViaCell, Marc acquired numerous appointments within Genzyme. His most recent position was the Vice President of Global Marketing, where he was accountable for the commercial commencement of various products conveying rare disease societies worldwide. Furthermore, Marc was also the founder and Chairman of the board of directors of the compensation committee of Good Start Genetics, Inc. which was newly acquired by InVitae.

 

Renovia Inc. is set to proceed with with the production of various products associated with pelvic floor disorders. Recently, the company closed a $32 million Series B round, which is the second round of financing for a business through any type of investment, including private equity investors and venture capitalists. One of the early investors in Renovia was Longwood Fund, with their funding contributing to the testing and development of four additional diagnostic and therapeutic products. Longwood Fund is an investing group which primarily focuses on health care. Additionally, the company received $10 million in venture debt.

 

Renovia Inc. is fabricating several diagnostic and therapeutic products aimed at treating pelvic floor disorders such as urinary incontinence. Researchers estimate that this disease affects over 250 million women globally. In April of 2018, the company received its initial Food and Drug Administration approval for Leva, their first product. Learn more: https://gazetteday.com/2018/10/marc-beer-funding-renovia/

 

Marc Beer was nothing less than thrilled and appreciative of the new funding and support. He articulated how he intends to lead Renovia’s development by combining innovation as well as proprietary sensor technologies with a “digital health platform”.

 

Copyright © 2019. Powered by WordPress & Romangie Theme.